# Butterfly Network Surges 21% on Compass AI Launch, New Certifications, and Upbeat Guidance

> Butterfly's Compass AI makes POCUS easier to run at scale-management, documentation, and billing. Security gains and iQ access progress come as investors lean in despite losses.

- Type: AI news
- Page: https://completeaitraining.com/news/butterfly-network-surges-21-on-compass-ai-launch-new/
- Published: 2025-11-23
- Updated: 2025-11-23
- Author: Jeroen Erne
- Jobs: Healthcare
- Reading time: 3 min

### Butterfly Network unveils Compass AI for POCUS: what it means for healthcare teams

Butterfly Network's stock \[NYSE: BFLY\] jumped 21.12% on November 22, 2025, after a week of steady headlines and clear execution. The core story for clinicians and hospital leaders: an AI-driven platform designed to make point-of-care ultrasound (POCUS) easier to run at scale, safer to document, and simpler to pay for.

#### What Compass AI brings to your ultrasound program

- **Program management:** Central oversight for devices, users, and utilization across departments and sites.
- **Documentation compliance:** Tools to tighten image labeling, exam notes, and billing inputs so records don't get stuck in review.
- **Revenue capture:** Cleaner documentation supports coding accuracy and reduces missed claims.
- **Quality assurance:** Consistent workflows and review loops to standardize bedside imaging across providers.

For ED, critical care, and hospitalist teams rolling out POCUS, this removes a lot of friction that usually shows up after the pilot phase-governance, consistency, and billing.

#### Access and affordability: iQ product line

Butterfly highlighted continued progress on accessibility and affordability with the iQ devices. The practical takeaway: more clinicians can carry ultrasound into the exam room, rural clinics, or home visits without waiting on a cart or a sonography slot.

#### Security and certifications

The company reported new international certifications in information security. For hospital IT and compliance, that signals attention to data handling, auditability, and third-party risk standards that support enterprise deployment.

If your organization is mapping requirements, the [HIPAA Security Rule](https://www.hhs.gov/hipaa/for-professionals/security/index.html?ref=completeaitraining.com) remains a useful anchor for administrative, physical, and technical safeguards.

#### Investor and industry engagement

- Participation in the UBS Global Healthcare Conference to spotlight digital advances and accessibility.
- Planned appearance at the 8th Annual Evercore Healthcare Conference, including fireside chats and 1:1 investor meetings.

These touchpoints matter for customers too. They pressure-test the roadmap, surface enterprise needs, and keep capital within reach.

#### Key numbers healthcare leaders should know

- **Q3 revenue:** $21.5M, slightly above expectations; management reaffirmed full-year guidance of $91M-$95M.
- **Margins and profitability:** Gross margin at 43.3%; EBIT margin at -89.1% and profit margin at -90.31%, reflecting scale-up and operating inefficiencies to work through.
- **Net loss:** $33.9M in the quarter.
- **Liquidity:** $144.2M in cash and equivalents as of September; management cited lower cash burn and progress on enterprise readiness and AI features.
- **Valuation context:** Enterprise value around $139.43M and a price-to-sales ratio near 6.63, which some analysts view as stretched relative to current profitability.

Analyst sentiment is positive, citing the AI platform launch, security posture, and a cleaner operating story. The company also reported a 5% year-over-year revenue increase.

#### Technical snapshot (informational)

Recent trading showed a move from $2.60 intraday lows to a $2.81 close after testing $3.09, accompanied by higher volume. Some analyst notes cite $2.81 as a level to watch, with opinions calling out $2.60-$2.65 as an area of interest and $3.25 as a near-term target. This is market commentary, not a recommendation.

#### Why this matters for your care setting right now

- **POCUS governance:** Define credentialing, image review standards, and escalation pathways before scaling beyond the pilot.
- **Documentation to billing:** Map exam templates to codes, link image requirements to claims, and run spot audits to reduce denials.
- **Security review:** Run a quick threat model with IT: identity, access, device loss, encryption, and vendor incident response.
- **Training and adoption:** Pair clinical education with workflow checklists so bedside imaging doesn't slow throughput.
- **Data feedback loop:** Track utilization, exam quality, and documented clinical impact to justify further deployment.

#### Near-term catalysts to monitor

- Compass AI rollout and customer case studies that show measurable improvements in documentation and revenue capture.
- Updates from UBS and Evercore events, particularly around enterprise deals and integrations.
- Fourth-quarter revenue trajectory versus guidance and any changes in cash burn.

#### Resources

- [FDA: AI/ML-enabled medical devices](https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices?ref=completeaitraining.com)
- [AI upskilling by job role (including healthcare)](https://completeaitraining.com/courses-by-job/)

Bottom line: Compass AI targets real operational pain points-governance, documentation, and revenue capture-while security certifications and stronger investor engagement add momentum. The financial picture still shows losses, but guidance remains intact and interest from the street is clear.

**This is stock news, not investment advice.**

---

This is the Markdown form of https://completeaitraining.com/news/butterfly-network-surges-21-on-compass-ai-launch-new/. The whole site is mapped at https://completeaitraining.com/llms.txt.
